Millennium Management’s Charles River Laboratories CRL Stock Holding History

Millennium Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35,900	Closed	-$7.16M	–	5818
2025 Q4	$7.16M	Buy	+35,900	New	+$6.51M	﹤0.01%	2629
2025 Q3	–	Sell	-46,500	Closed	-$7.06M	–	6082
2025 Q2	$7.06M	Buy	+46,500	New	+$6.2M	﹤0.01%	2624
2024 Q4	–	Sell	-10,600	Closed	-$2.09M	–	6029
2024 Q3	$2.09M	Sell	10,600 -20,600	-66%	-$4.28M	﹤0.01%	3668
2024 Q2	$6.45M	Buy	31,200 +14,900	+91%	+$3.38M	﹤0.01%	2483
2024 Q1	$4.42M	Buy	16,300 +6,300	+63%	+$1.5M	﹤0.01%	2987
2023 Q4	$2.36M	Sell	10,000 -40,100	-80%	-$7.89M	﹤0.01%	3475
2023 Q3	$9.82M	Buy	50,100 +26,800	+115%	+$5.5M	0.01%	2072
2023 Q2	$4.9M	Buy	23,300 +13,300	+133%	+$2.65M	﹤0.01%	2694
2023 Q1	$2.02M	Buy	+10,000	New	+$2.27M	﹤0.01%	3432
2022 Q4	–	Sell	-32,400	Closed	-$6.38M	–	6631
2022 Q3	$6.38M	Sell	32,400 -2,600	-7%	-$561K	﹤0.01%	2656
2022 Q2	$7.49M	Buy	35,000 +22,000	+169%	+$5.38M	﹤0.01%	2364
2022 Q1	$3.69M	Buy	13,000 +10,000	+333%	+$3.08M	﹤0.01%	3266
2021 Q4	$1.13M	Buy	+3,000	New	+$1.17M	﹤0.01%	4302
2020 Q1	–	Sell	-135,000	Closed	-$20.6M	–	3941
2019 Q4	$20.6M	Buy	+135,000	New	+$18.7M	0.03%	817
2019 Q1	–	Sell	-35,000	Closed	-$3.96M	–	4018
2018 Q4	$3.96M	Buy	+35,000	New	+$4.38M	0.01%	1743
2018 Q2	–	Sell	-10,000	Closed	-$1.07M	–	3834
2018 Q1	$1.07M	Buy	+10,000	New	+$1.08M	﹤0.01%	2653
2014 Q1	–	Sell	-5,000	Closed	-$265K	–	3504
2013 Q4	$265K	Buy	+5,000	New	+$251K	﹤0.01%	3126

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Millennium Management's CRL Position: Q2 2026 in Review

Millennium Management reduced its Charles River Laboratories (CRL) stake by 48% in Q2 2026, selling an estimated $79.7M and leaving 486,462 shares worth $110M. The position accounts for 0.04% of the portfolio, ranked #469.

Millennium Management first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. The position peaked at $161M in Q1 2026. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Millennium Management held 486,462 shares of Charles River Laboratories worth $110M as of Q2 2026.
Millennium Management sold 447,583 Charles River Laboratories shares in Q2 2026, an estimated $79.7M.
Charles River Laboratories made up 0.04% of Millennium Management's portfolio in Q2 2026, its #469 holding.
Millennium Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
Millennium Management's Charles River Laboratories position peaked at $161M in Q1 2026.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.